Effects of Fish Oil Supplementation on Markers of the Metabolic Syndrome
Objective
To investigate whether fish oil affects cardiovascular risk factors during the adolescent growth spurt.
Study design
A total of 78 boys age 13-15 years with a mean body fat percentage of 30% ± 9% were randomly assigned to consume fish oil (providing 1.5 g of n-3 long-chain polyunsaturated fatty acid/day) or vegetable oil (control) for 16 weeks. The oils were included in bread.
Results
After the intervention, the red blood cell (RBC) content of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were 1.2% ± 0.5% and 6.7% ± 1.6%, respectively, in the those receiving fish oil (FO group), compared with 0.6% ± 0.3% and 4.1% ± 0.9% in the control group. Systolic blood pressure (SBP) was 3.8 ± 1.4 mm Hg lower (P < .006) and diastolic blood pressure (DBP) was 2.6 ± 1.1 mm Hg lower (P < .01) in the FO group compared with the control group. Plasma triacylglycerol (TAG) concentration and insulin sensitivity were unaffected by either of the treatments. Plasma high-density lipoprotein (HDL) and non-HDL cholesterol were increased by 5% and 7%, respectively, in the FO group, and by 2% and 0% in the control group (P < .01-.02). The changes in RBC EPA content were inversely correlated with the changes in SBP and DBP and directly correlated with the increases in HDL cholesterol and non-HDL cholesterol concentrations. No association was seen between RBC EPA and plasma TAG concentration or insulin sensitivity.
Conclusion
Fish oil improves BP in normotensive and normolipidemic slightly overweight adolescent boys.
BP, Blood pressure, DBP, Diastolic blood pressure, DHA, Docosahexenoic acid, DPA, Docosapentenoic acid, EPA, Eicosapentenoic acid, FO, Fish oil, HbA1c, Hemoglobin A1c, HDL, High-density lipoprotein, LCPUFAs, Long-chain polyunsaturated fatty acids, LDL, Low-density lipoprotein, MUFAs, Monounsaturated fatty acids, OGTT, Oral glucose tolerance test, RBC, Red blood cell, SBP, Systolic blood pressure, SFAs, Saturated fatty acids, TAG, Triacylglycerol
To access this article, please choose from the options below
Supported by the Danish Council for Strategic Research. The intervention bread was sponsored by Kohberg A/S, which had no influence on the interpretation of the data or the writing of this article. The authors declare no conflicts of interest.
Clinical Trials database registration (clinicaltrials.gov): NCT00929552.
PII: S0022-3476(10)00301-X
doi:10.1016/j.jpeds.2010.04.001
© 2010 Mosby, Inc. All rights reserved.
